The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). This shows the true impact to be far higher

Supplementation with a selenium-based antioxidant compound decreased the risk of developing new polyps of the large bowel - called colorectal metachronous adenomas - in people who previously had colorectal polyps removed.

The natural compound xanthohumol blocks the effects of the male hormone testosterone, therefore aiding in the prevention of prostate cancer.

Cell Therapeutics, Inc. announced that Ruth Pettengell, M.D. of St. George's Hospital, University of London during a session at the 2009 American Society of Hematology Annual Meeting updated results from the pivotal phase III EXTEND (PIX 301) clinical trial of

There have been significant scientific advances in the field of blood cancers, and leading experts continue to gain a better understanding of how certain diseases progress in order to discover new treatment options and provide patients with the best care.

GlaxoSmithKline announced updated long-term survival data from two Phase II studies of BEXXAR (tositumomab and iodine I-131 tositumomab) used in either patients with previously untreated cancer of the immune system (follicular lymphoma) or in patients with cancer of the lymphocytes

Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation, announced that it has signed an exclusive License Agreement with Wayne State University to key intellectual property covering discoveries of biomarkers of ovarian cancer.

Investigators publish new data in the report 'GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells.' According to recent research from Italy, In this paper, we describe the effects of the expression

They were only in their late 30s, but Amy Cosgriff and Rhonda Milligan decided to have their ovaries removed a few months ago. Milligan also elected to get rid of both breasts. These two healthy, cancer-free women -- good friends

AstraZeneca announced that data from a Phase III study of postmenopausal women with hormone receptor-positive advanced breast cancer presented at the San Antonio Breast Cancer Symposium (Abstract 25) showed treatment with fulvestrant (FASLODEX) 500 mg reduced the risk of disease

Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called Twist may be the proverbial red flag that can accurately distinguish stem cells that drive aggressive,

The spread, or metastasis, of individual breast cancer cells from the main tumor into the blood circulation to the lungs and other body tissues and organs is under the control of a growth factor abbreviated TGFb, according to a study

Nearly half of breast cancer survivors suffer from persistent pain, even two to three years after surgery, a study shows. Almost 60% of the 3,253 women surveyed experience other symptoms of nerve damage, such as numbness or tenderness, according to

Laufer was diagnosed with a perplexing condition called ductal carcinoma in situ, or DCIS, a growth of malignant cells inside the milk ducts of the breast. Though some doctors describe the condition to patients as a very early breast cancer,

Knowing which health conditions are common to your specific age group can help you determine the questions you should ask at your next doctor's appointment. Although diseases such as breast cancer and other illnesses are more prevalent at some ages

Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. D. Anderson Cancer Center

The methods and outcomes for stem cell transplants are constantly improving as leading experts continue to investigate new approaches for reducing the serious adverse events associated with the procedure. Research presented today at the 51st Annual Meeting of the American

The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers reported at the 51st Annual Meeting of the American Society of Hematology.

U.S. Sens. Sherrod Brown (D-OH) and Kay Bailey Hutchison (R-TX) announced a bipartisan amendment to the health reform bill which would protect access to clinical trials for patients with life-threatening diseases. The amendment would prohibit insurers from dropping a policyholder's

About 100,500 new cases of cancer are caused by obesity every year, according to the most comprehensive attempt ever to estimate the cancers attributed to extra weight. The analysis, released today by the American Institute for Cancer Research, is based